SHERI MEHL: Open Payments
NPI 1952720237 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,301 in 148 payments from 29 companies in 2025. Trend: 2023 $3,232 · 2024 $3,273 · 2025 $3,301
Food & beverage: $3,301
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $310 |
| PFIZER INC. | 35 | $285 |
| ABBVIE INC. | 12 | $253 |
| Novartis Pharmaceuticals Corporation | 19 | $246 |
| Celgene Corporation | 10 | $228 |
| AstraZeneca Pharmaceuticals LP | 2 | $218 |
| Eisai Inc. | 7 | $156 |
| Lilly USA, LLC | 7 | $155 |
| Axsome Therapeutics, Inc. | 4 | $142 |
| Novo Nordisk Inc | 2 | $137 |
Products named: ZEPOSIA, NURTEC ODT, KESIMPTA, Leqembi, KISUNLA, Symbravo, Ozempic, BOTOX.
Industry payments across FL — which companies pay providers there.
